Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis.
Galfrascoli E, Piva S, Cinquini M, Rossi A, La Verde N, Bramati A, Moretti A, Manazza A, Damia G, Torri V, Muserra G, Farina G, Garassino MC; ORION Collaborative Group.
Galfrascoli E, et al. Among authors: garassino mc.
Dig Liver Dis. 2011 Apr;43(4):286-94. doi: 10.1016/j.dld.2010.10.010. Epub 2010 Dec 13.
Dig Liver Dis. 2011.
PMID: 21146479
Review.